Shao-Lee Lin, Chief Executive Officer at Cue Biopharma, Inc. (CUE), sold 11,087 shares at $27.50 ($305K) on 2026-10-12, disclosed to the SEC on 2026-10-14.
Open-market sale of $305k CUE by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.50 | 10,000 | $275K | 90.0% |
| 2 | $28.05 | 1,087 | $30K | 10.0% |
| Total | $27.55 avg | 11,087 | $305K | 100% |
| Filing → |
| SLRN | SELL | 2024-02-22 | $239K | — | Filing → |
| SLRN | SELL | 2024-01-04 | $158K | — | Filing → |